Variant report
Variant | esv3368596 |
---|---|
Chromosome Location | chr1:103646864-103649337 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541210260 | chr1:103646884-103646885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149125487 | chr1:103646911-103646912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs60949157 | chr1:103646919-103646920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs67504438 | chr1:103646921-103646922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs68137445 | chr1:103646922-103646923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs67726949 | chr1:103646930-103646931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572892965 | chr1:103646944-103646945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs527513057 | chr1:103647021-103647022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545613087 | chr1:103647030-103647031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563903031 | chr1:103647037-103647038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188044100 | chr1:103647038-103647039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549998680 | chr1:103647067-103647068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368378463 | chr1:103647091-103647092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568010600 | chr1:103647102-103647103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373475435 | chr1:103647202-103647203 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528871741 | chr1:103647250-103647251 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10081992 | chr1:103647329-103647330 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143292932 | chr1:103647333-103647334 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs375959984 | chr1:103647349-103647350 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571523252 | chr1:103647351-103647352 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558392868 | chr1:103647394-103647395 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138846733 | chr1:103647403-103647404 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537392788 | chr1:103647404-103647405 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141769373 | chr1:103647419-103647420 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573986438 | chr1:103647472-103647473 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145484377 | chr1:103647502-103647503 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552918821 | chr1:103647517-103647518 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577729463 | chr1:103647550-103647551 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545057010 | chr1:103647552-103647553 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192484353 | chr1:103647574-103647575 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs559372737 | chr1:103647615-103647616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543392778 | chr1:103647631-103647632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185037739 | chr1:103647632-103647633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs114310361 | chr1:103647674-103647675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561189451 | chr1:103647696-103647697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138006137 | chr1:103647706-103647707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs113865238 | chr1:103647726-103647727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188984143 | chr1:103647732-103647733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs7517870 | chr1:103647740-103647741 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs181669601 | chr1:103647741-103647742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533063003 | chr1:103647742-103647743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs529668310 | chr1:103647793-103647794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184024088 | chr1:103647808-103647809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs189605302 | chr1:103647820-103647821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181596564 | chr1:103647826-103647827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185922833 | chr1:103647842-103647843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553808263 | chr1:103647847-103647848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191163454 | chr1:103647853-103647854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549440996 | chr1:103647871-103647872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181812516 | chr1:103647876-103647877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:103646000-103647200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr1:103646000-103647200 | Enhancers | HSMM | muscle |
3 | chr1:103646000-103647200 | Enhancers | NH-A | brain |
4 | chr1:103646000-103647400 | Enhancers | Muscle Satellite Cultured Cells | -- |
5 | chr1:103646000-103647400 | Enhancers | Fetal Heart | heart |
6 | chr1:103646800-103647200 | Enhancers | A549 | lung |
7 | chr1:103647200-103659400 | Weak transcription | HSMM | muscle |
8 | chr1:103647400-103647600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |